Brief: Pharma Equity Unit Reponex Receives Grant Of U.S. Patent

Pharma Equity A/S

31/10/2023 11:16

Oct 31 (Reuters) - Pharma Equity Group A/S  PEGRP.CO :
    * PHARMA EQUITY GROUP’S SUBSIDIARY COMPANY (REPONEX
PHARMACEUTICALS A/S) HAVE RECEIVED GRANT OF US PATENT FOR A
METHOD OF TREATMENT ON ITS TOPICAL WOUND-HEALING COMPOSITION
    * PATENT IS VALID UNTIL 2039

Source text for Eikon:  ID:nGNE14J7LH 
Further company coverage:  PEGRP.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))